Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dolutegravir and Its Combination Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dolutegravir and Its Combination Drugmarket, defines the market attractiveness level of Dolutegravir and Its Combination Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dolutegravir and Its Combination Drug industry, describes the types of Dolutegravir and Its Combination Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dolutegravir and Its Combination Drug market and the development prospects and opportunities of Dolutegravir and Its Combination Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dolutegravir and Its Combination Drug market in Chapter 13.
By Player:
LAURUS Labs
Shanghai Desano Pharmaceuticals
Adcock Ingram Limited
Aurobindo Pharma
Mylan
ViiV Healthcare (GSK)
By Type:
Dolutegravir
Abacavir/Dolutegravir/Lamivudine
Dolutegravir/Rilpivirine
By End-User:
Hospital
Clinic
Drug Center
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dolutegravir and Its Combination Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dolutegravir and Its Combination Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dolutegravir and Its Combination Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dolutegravir and Its Combination Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dolutegravir and Its Combination Drug Market Analysis and Outlook to 2022
-
7.1 Global Dolutegravir and Its Combination Drug Consumption (2017-2022)
-
7.2 United States Dolutegravir and Its Combination Drug Consumption (2017-2022)
-
7.3 Europe Dolutegravir and Its Combination Drug Consumption (2017-2022)
-
7.4 China Dolutegravir and Its Combination Drug Consumption (2017-2022)
-
7.5 Japan Dolutegravir and Its Combination Drug Consumption (2017-2022)
-
7.6 India Dolutegravir and Its Combination Drug Consumption (2017-2022)
-
7.7 South Korea Dolutegravir and Its Combination Drug Consumption (2017-2022)
8 Region and Country-wise Dolutegravir and Its Combination Drug Market Analysis and Outlook to 2028
-
8.1 Global Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
-
8.2 United States Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
-
8.3 Europe Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
-
8.4 China Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
-
8.5 Japan Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
-
8.6 India Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Dolutegravir and Its Combination Drug Consumption Forecast (2022-2028)
9 Global Dolutegravir and Its Combination Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Dolutegravir and Its Combination Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dolutegravir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Abacavir/Dolutegravir/Lamivudine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dolutegravir/Rilpivirine Consumption and Growth Rate (2017-2022)
-
9.2 Global Dolutegravir and Its Combination Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Dolutegravir and Its Combination Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dolutegravir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Abacavir/Dolutegravir/Lamivudine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dolutegravir/Rilpivirine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Dolutegravir and Its Combination Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dolutegravir and Its Combination Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dolutegravir and Its Combination Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dolutegravir and Its Combination Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dolutegravir and Its Combination Drug Market Competitive Analysis
-
14.1 LAURUS Labs
-
14.1.1 LAURUS Labs Company Details
-
14.1.2 LAURUS Labs Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 LAURUS Labs Dolutegravir and Its Combination Drug Product and Service
-
14.2 Shanghai Desano Pharmaceuticals
-
14.2.1 Shanghai Desano Pharmaceuticals Company Details
-
14.2.2 Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Product and Service
-
14.3 Adcock Ingram Limited
-
14.3.1 Adcock Ingram Limited Company Details
-
14.3.2 Adcock Ingram Limited Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Adcock Ingram Limited Dolutegravir and Its Combination Drug Product and Service
-
14.4 Aurobindo Pharma
-
14.4.1 Aurobindo Pharma Company Details
-
14.4.2 Aurobindo Pharma Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Aurobindo Pharma Dolutegravir and Its Combination Drug Product and Service
-
14.5 Mylan
-
14.5.1 Mylan Company Details
-
14.5.2 Mylan Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mylan Dolutegravir and Its Combination Drug Product and Service
-
14.6 ViiV Healthcare (GSK)
-
14.6.1 ViiV Healthcare (GSK) Company Details
-
14.6.2 ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dolutegravir and Its Combination Drug
-
Figure Dolutegravir and Its Combination Drug Picture
-
Table Global Dolutegravir and Its Combination Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dolutegravir and Its Combination Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dolutegravir and Its Combination Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dolutegravir and Its Combination Drug Consumption by Country (2017-2022)
-
Figure United States Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure China Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure India Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dolutegravir and Its Combination Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Dolutegravir and Its Combination Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dolutegravir and Its Combination Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dolutegravir Consumption and Growth Rate (2017-2022)
-
Figure Global Abacavir/Dolutegravir/Lamivudine Consumption and Growth Rate (2017-2022)
-
Figure Global Dolutegravir/Rilpivirine Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Center Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Dolutegravir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Abacavir/Dolutegravir/Lamivudine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dolutegravir/Rilpivirine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dolutegravir and Its Combination Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dolutegravir and Its Combination Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table LAURUS Labs (Foundation Year, Company Profile and etc.)
-
Table LAURUS Labs Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table LAURUS Labs Dolutegravir and Its Combination Drug Product and Service
-
Table Shanghai Desano Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Desano Pharmaceuticals Dolutegravir and Its Combination Drug Product and Service
-
Table Adcock Ingram Limited (Foundation Year, Company Profile and etc.)
-
Table Adcock Ingram Limited Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adcock Ingram Limited Dolutegravir and Its Combination Drug Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Dolutegravir and Its Combination Drug Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Dolutegravir and Its Combination Drug Product and Service
-
Table ViiV Healthcare (GSK) (Foundation Year, Company Profile and etc.)
-
Table ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ViiV Healthcare (GSK) Dolutegravir and Its Combination Drug Product and Service
-
